Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Rifalazil |
EINECS | N/A |
CAS No. | 129791-92-0 | Density | 1.36g/cm3 |
PSA | 230.66000 | LogP | 6.57360 |
Solubility | N/A | Melting Point |
195-200° (dec) |
Formula | C51H64 N4 O13 | Boiling Point | 1048.6°Cat760mmHg |
Molecular Weight | 941.088 | Flash Point | 588°C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
KRM 1648;Rifalazil; |
Article Data | 2 |
Molecular Structure of Rifalazil (CAS No.129791-92-0):
Molecular Formula: C51H64N4O13
Molecular Weight: 941.0729
CAS No: 129791-92-0
H bond acceptors: 17
H bond donors: 5
Freely Rotating Bonds: 10
Polar Surface Area: 226.22 Å2
Index of Refraction: 1.633
Molar Refractivity: 246.03 cm3
Molar Volume: 688.1 cm3
Surface Tension: 49 dyne/cm
Density: 1.36 g/cm3
Flash Point: 598.2 °C
Enthalpy of Vaporization: 163.55 kJ/mol
Boiling Point: 1065.6 °C at 760 mmHg
Vapour Pressure: 0 mmHg at 25°C
InChI: InChI=1/C51H64N4O13/c1-24(2)23-54-16-18-55(19-17-54)32-21-33(57)39-35(22-32)67-48-40(52-39)36-37-44(60)30(8)47-38(36)49(62)51(10,68-47)65-20-15-34(64-11)27(5)46(66-31(9)56)29(7)43(59)28(6)42(58)25(3)13-12-14-26(4)50(63)53-41(48)45(37)61/h12-15,20-22,24-25,27-29,34,42-43,46,57-60H,16-19,23H2,1-11H3,(H,53,63)/b13-12+,20-15+,26-14-/t25-,27+,28+,29+,34-,42-,43+,46+,51-/m0/s1
InChIKey: UEFHFKKWYKVLDC-HTQYORAHBS
Std. InChI: InChI=1S/C51H64N4O13/c1-24(2)23-54-16-18-55(19-17-54)32-21-33(57)39-35(22-32)67-48-40(52-39)36-37-44(60)30(8)47-38(36)49(62)51(10,68-47)65-20-15-34(64-11)27(5)46(66-31(9)56)29(7)43(59)28(6)42(58)25(3)13-12-14-26(4)50(63)53-41(48)45(37)61/h12-15,20-22,24-25,27-29,34,42-43,46,57-60H,16-19,23H2,1-11H3,(H,53,63)/b13-12+,20-15+,26-14-/t25-,27+,28+,29+,34-,42-,43+,46+,51-/m0/s1
Std. InChIKey: UEFHFKKWYKVLDC-HTQYORAHSA-N
Synonyms of Rifalazil (CAS No.129791-92-0): (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,12,21,23-tetrahydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-10-[4-(2-methylpropyl)piperazin-1-yl]-1,6,15-trioxo-1,2-dihydro-6H-2,7-(epoxypentadeca[1,11,13]trienoimino)[1]benzofuro[4,5-a]phenoxazin-25-yl acetate ; (2S,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-5,12,21,23-tetrahydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-10-[4-(2-methylpropyl)piperazin-1-yl]-1,6,15-trioxo-1,2-dihydro-6H-2,7-(epoxypentadeca[1,11,13]trienoimino)[1]benzofuro[4,5-a]phenoxazin-25-yl acetate ; (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E)-2,15,17,32-Tetrahydroxy-30-(4-isobutylpiperazin-1-yl)-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,37-trioxo-8,27,38-trioxa-24,34-diazahexacyclo[23.11.1.1~4,7~.0~5,36~.0~26,35~.0~28,33~]octatriaconta-1(36),2,4,9,19,21,25,28,30,32,34-undecaen-13-yl acetate ; (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-Tetrahydroxy-30-(4-isobutylpiperazin-1-yl)-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,37-trioxo-8,27,38-trioxa-24,34-diazahexacyclo[23.11.1.1~4,7~.0~5,36~.0~26,35~.0~28,33~]octatriaconta-1(36),2,4,9,19,21,25,28,30,32,34-undecaen-13-yl acetate